Brief: Mei Pharma Reports Third Quarter Fiscal Year 2023 Results And Operational Highlights
11/05/2023 21:44
MEI Pharma Inc MEIP.O :
* MEI PHARMA REPORTS THIRD QUARTER FISCAL YEAR 2023 RESULTS
AND
OPERATIONAL HIGHLIGHTS
* MEI PHARMA INC Q3 LOSS PER SHARE $2.32
Source text for Eikon: ID:nBw3lWXqda
Further company coverage: MEIP.O
Recent news on Lite Strategy
See all newsBrief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens
U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations